22nd May 2006 15:52
Ark Therapeutics Group PLC22 May 2006 Ark Therapeutics Group plc (the "Company") 22 May 2006 Directors' shareholdings The Company announces that, following admission to listing on the Official Listand to trading on the London Stock Exchange's main market for listed securitiesearlier today of 31,874,514 new Ordinary Shares of 1 pence each in the Company("Ordinary Shares") issued pursuant to the Company's Placing and Open Offerannounced on 27 April 2006, the Company has been informed today of the followingdealings by certain of its Directors: Director Number of Ordinary Resultant holding of Percentage of Shares acquired* Ordinary Shares enlarged issued share capital following the Placing and Open Offer Dennis Turner 47,000 143,002 0.09%Dr Nigel Parker 4,706 2,891,373 1.81%Martyn Williams 4,706 548,104 0.34%Peter Keen 35,265(1) 194,965(2) 0.12%David Prince 11,765 11,765 0.01%Sir Mark Richmond 14,118 14,118 0.01% * All Ordinary Shares acquired at 85 pence each. (1) 23,500 of these Ordinary Shares were purchased by Mr Keen's retirement benefit scheme, of which Mr Keen is a joint trustee and sole member. (2) 183,200 of these Ordinary Shares are beneficially held by Mr Keen's retirement benefit scheme. Enquiries: Ark Therapeutics Group plc Tel: 020 7388 7722Nick Plummer, Company Secretary This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
PVG.L